FDA to remove suicide warnings for weight loss drugs
The FDA wants suicide warnings to be taken off of some popular weight-loss medications.
The FDA wants suicide warnings to be taken off of some popular weight-loss medications.
A drug that helps people lose weight now has a slimmer price tag.
Eli Lilly says it will file for regulatory approval for its GLP1 weight loss pill called Orforglipron.
The move follows criticism from federal lawmakers and advocacy groups.